Faeth Therapeutics Stock Forecast

Hold candidate since Aug 10, 2026

The Faeth Therapeutics, Inc. stock price gained 17.14% on the last trading day (Monday, 10th Aug 2026), rising from $24.39 to $28.57. During the last trading day the stock fluctuated 23.08% from a day low at $24.24 to a day high of $29.84. The price has fallen in 8 of the last 10 days and is down by -2.29% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 57 thousand more shares were traded than the day before. In total, 258 thousand shares were bought and sold for approximately $7.38 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 54.29% during the next 3 months and, with a 90% probability hold a price between $31.03 and $63.34 at the end of this 3-month period.

FTH Signals & Forecast

The Faeth Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $26.02 and $27.16. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, July 10, 2026, and so far it has fallen -20.99%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Faeth Therapeutics, Inc. stock

Faeth Therapeutics, Inc. finds support from accumulated volume at $28.37 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $5.60 between high and low, or 23.08%. For the last week, the stock has had daily average volatility of 13.08%.

Our recommended stop-loss: $27.31 (-4.40%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 21 days ago.)

Trading Expectations (FTH) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Faeth Therapeutics, Inc. to open at $27.55, and during the day (based on 14 day Average True Range), to move between $26.96 and $30.18, which gives a possible trading interval of +/-$3.23 (+/-11.98%) up or down from last closing price. If Faeth Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 11.98% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $28.66 (0.32%) than the support at $28.37 (0.70%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Faeth Therapeutics, Inc. stock A Buy?

Faeth Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: 0.334 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $27.55 ( 3.58%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk